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The role of T and B lymphocytes in the human immune response has 
been studied in allergic and asthmatic patients by many investigators. 
Theories of suppressed cellular immunity have been reported showing 
decreased levels of T cells in peripheral blood. Elevated levels of 
IgE, an antibody, have been reported in these conditions, but not shown 
to be significant in distinguishing the different types of asthma. 
A double blind study of 19 allergic and 42 asthmatic individuals 
was conducted measuring T and B cell levels and IgE levels. The asth-
matic group was subdivided into three types, intrinsic, extrinsic and 
mixed. The possible effects of corticosteroids were considered with 
each group since 47 out of the total 60 patients studied were steroid 
dependent. T and B cells were enumerated by rosette method. This 
method was developed and normal values established. IgE levels were 
measured by radioimmunoassay. 
Results showed all steroid dependent patients, allergic and asth-
matic, had normal or slightly elevated T and/or B cell levels and IgE 
levels. The corticosteroids appeared to have a stimulative effect 
~ 
rather than a suppressive effect on T and B cells and IgE as previous 
investigators have reported. Allergic or asthmatic conditions cannot be 
distinguished on the basis of T and B cell levels. IgE levels were found 
to be highly significant at a 95% confidence level in distinguishing 
intrinsic asthma from extrinsic asthma. 
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Individuals who develop a cough, wheeze, shortness of breath, re-
current colds, sinus infections, headaches, ear involvement, skin man-
ifestations, gastrointestinal complaints, drenching sweats, hives or 
urticaria, eczema, or any combination of these, may be allergic* or 
atopic*. Ten to twenty per cent of the population of the United States 
suffers to a greater or lesser degree with allergies to allergens such 
rs rass pollen, animal danders, mites in house dust, etc. (1). For 
those un ortunates sensitized to foods such as strawberries, the price 
of indulgence may result in a generalized urticaria or hives. In ex-
treme cases, death can even occur in highly sensitized persons who re-
act to such things as insect bites and injection of penicillin anti-
b "ot ' c through anaphylaxis. 
These allergic or atopic symptoms are the result of the body's im-
mune system responding to the foreign substance. The function of the 
immune system is to recognize foreign agents that might be damaging to 
the body and to neutralize these agents, thereby maintaining the in-
ternal metabolic environment in a steady state. The core of this de-
fense is the lymphoid system, comprised cf immunocompetent cells --
the lymphocytes, a type of white blood cell. The present concepts of 
the immune system were derived from numerous animal experiments and 
*Allergic refers to individuals who have allergic symptoms, but do 
not have elevated blood levels of the antibody IgE. Atopic refers to 
individuals who exhibit allergic symptoms and have elevated IgE levels. 
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from studies of human immune deficiency diseases. 
Development of the lymphoid system occurs along two independent 
pathways ~eading to functionally and morphologically distinct popula-
tions of immunocompetent cells (2). Some lymphocytes migrate from the 
bone marrow via the blood stream to the thymus gland for processing 
and are destined to become "T" cells. Others which pass through 
lymphoid tissue, the bone marrow, are the "B" cells. 
Tite T cells make up about 70 to 80% of the circulating pool of 
lymphoc tes ·n peripheral blood (3). These cells function as mediators 
of cellular immunity, and are active in such functions as tuberculin 
sensitiv · ty, graft rejection, rejection to some virus and fungal in-
ections, tumor surveillance, delayed contact sensitivities, immuno-
lo · · 1 memory, and autoimmune disease (4-6). T cell also modifies 
B c 11 unction (7-8). 
lhe B c 11 comprises approximately 20% of the circulating lympho-
cytes in peripheral blood (9). B cells become plasma cells upon 
appropriate stimulation by a foreign agent. Plasma cells secrete pro-
teins called immunoglobulins or antibodies. The B cell in association 
with T cell produces a variety of classes of immunoglobulins -- IgG, 
IgA, Igl·1, IgD, and IgE (10). 
Many other diseases besides allergy exhibit the same kinds of 
symptoms, but the hallmark of the phenomenon of allergy or atopy is 
the increased levels of the immunoglobulin E. This immunoglobulin has 
a propensity to attach onto a tissue mast cell, blood basophils, and 
blood neutrophils. These cells, particularly abundant in the skin and 
bronchial tissue, contain many cytoplasmic granules which are the 
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reservoirs for the mediators of the allergic reactions. These mediat-
ors are histamine, slow reacting substance of anaphylaxis (SRSA), 
eosinophiL chemotactic factor, prothrombin activating factor, and sero-
tonin. When the IgE on the mast cell comes in contact with a specific 
allergen and aggregates, the cell undergoes degranulation and subse-
quent rupture with the release of the mediators. Release of the 
pharmacologically active mediators from the ruptured cells in the 
bronchial tree, nasal mucosa, or conjunctival tissue produces the 
s mptoms of asthma or hayfever. In the case of food allergies, aller-
genic substances from the allergen such as strawberries are absorbed 
from the gut into the blood stream and react with the IgE bound cell in 
the skin producing urticaria as symptoms. There is a strong genetic 
Jredisposition to the development of allergic manifestations, usually 
parents or siblings of allergic patients will also have a history of 
lle g "es. The reasons for this are not yet understood. 
In addition to increased levels of IgE, allergic individuals gener-
ally exhibit an increase in eosinophils, a type of white blood cell. 
Eosinophils can be detected in the peripheral blood and in nasal smears. 
The significance of increased eosinophil levels is unknown at this time. 
THE ASTHMATIC STATE 
An allergic state, asthma, is of particular importance since 2 to 
3% of the general population develop this condition. Its etiology is 
still unknown. Asthma, although considered benign by many, is a 
chronic disease which has a yearly mortality rate of 0.2%. It is 
characterized as an obstructive bronchitis which has shown increased re-
sponsiveness of the trachea and bronchi to various stimuli. Characteris-
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tic asthmatic symptoms are bronchospasms, bronchial edema, and exces-
sive mucus secretions. These symptoms result from the action of hista-
mine and SRSA on smooth bronchial tissue causing it to contact and on 
exocrine glands causing bronchial hypersecretion (11). 
Asthmatics in general enjoy reasonably active lives with most ex-
periencing frequent recurrent attacks. Generally asthma is potentially 
reversible unless an acute phase, status asthmaticus, occurs. The 
acute phase is characterized by bronchospasms which become unresponsive 
to th usual medications (11). Status asthmaticus can result from over-
whelming exposure to an allergen, neglect of symptoms, inappropriate 
use of medications, emotional upsets, irritants, or respiratory tract 
infections. 
thma · s generally categorized into the following three groups, 
based upon reaction to allergens and the onset and duration of symptoms 
(11): 
1. Extrinsic asthma is caused by demonstrable allergens such as 
pollen, spores, dust, etc. Skin testing with these allergens 
shows areas of hardness surrounded by erythema. These reactions 
are commonly referred to as wheal and flare and are considered 
as positive skin tests. Frequently extrinsic asthmatics ex-
hibit atopic dermatitis and allergic rhinitis. Extrinsic 
asthma can persist from childhocd into adulthood with a quies-
cent period at puberty. 
2. Intrinsic asthma differs from extrinsic asthma in that it seems 
unrelated to any known allergen and skin tests are weak or 
negative to most antigens (allergens). Onset generally does 
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not develop until adult life and is associated with infections 
of the lower respiratory tract or paranasal sinus. It can be 
mistaken for chronic bronchitis. 
3. Mixed asthma is a combination of extrinsic and intrinsic 
asthma. 
GENERAL DIAGNOSTIC PARAMETERS OF ALLERGY 
The diagnosis of allergy or atopy depends largely on patient 
history. The various criteria that must be considered are family his-
to y (part' ularly parental), presence of several stigmata of allergy 
involving separate systems (such as chest and skin), active favorable 
response to antiallergenic medications (such as antihistamines and 
bronchodilators), demonstration of the patterns of allergic disease 
(such as known food or inhalant allergies, seasonal history, etc.), 
and finally presence of physical and laboratory corroboration (12). 
Two laboratory tests, eosinophil and IgE levels, are used to aid 
in the diagnosis of the allergic state. Skin testing and RAST test 
provide more specific information of what is the cause (the offending 
allergen) of the allergenic state. These tests are described as fol-
lows: 
1. Eosinophil levels. Eosinophile are found in peripheral blood 
and nasal smears. Eosinophilia is favored by the release of 
Eosinophil-Chemotactic Factor from degranulating IgE bound 
mast cells, blood basophils, and neutrophils. 
2. IgE levels. Increased blood levels of IgE is the hallmark of 
most atopic responses, but the elevation may not be striking. 
Normal blood levels are extremely low and comprise very little 
of the total immunoglobulins. A protective role for IgE has 
not been specifically shown, but there is some correlation 
with sino pulmonary infection. 
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3. Skin testing. Sensitivity to an allergen is assessed by the 
response to intradermal challenge. The skin provides a large 
area for testing for the presence of cytophilic IgE bound to 
tissue mast cells. The offending allergen will produce a wheal 
and erythema at the site of its injection due to the allergen 
b "nd "ng to IgE bound mast cell. This binding causes degranu-
laL ·on and release of histamine or other mediators. Reactions 
are read as positive based upon the size and redness of the 
er thema plus the timing of the response. 
4. RAS., test. The RAST test measures the amount of IgE antibody 
to a spec"fic allergen present in peripheral blood. The al-
lergen suspected is covalently coupled to a paper disc which 
then is treated with patient's serum. The amount of specific 
IgE bound to the paper is then estimated by addition of la-
belled anti-IgE antibody. 
ALLERGY AN !~ruNE DISORDER 
Allergic diseases are now recognized as disorders of the immune 
system. IgE is similar to other immunoglobulins in that its production 
is controlled by B cells. T cells have been shown to have both helper 
and suppressor functions on B cell activity (7-8) through biologically 
active mediators (13). An activated helper T cell can interact with 
the precursor cell into a mature B cell (plasma cell) which secretes 
IgE (14). Suppressor T cells may interfere with 1.) the activation of 
th helper T cells, 2.) the actual function of the helper T cell in 
terms of its facilitating interactions with the B cell, 3.) in the 
actual differentiation of the precursor B cells into a mature plasma 
cell, or 4.) the antibody production by exerting a direct inhibitory 
ef-ect on the fully matured plasma cells (14). 
' h critical role of T cells in helping and suppressing B cell 
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n 'bod product · on has been demonstrable in many animal models. Tada 
· nd h " . colleagues' studies on rats demonstrated for the first time the 
·· i · t n o ~· uppressor T cells exerting a very powerful negative regu-
o y to r production of IgE antibodies in this species (14-15). 
tz ' ud e in mice of the effects of irradiation or cyclophosphamide 
on cells provided direct evidence for the existence of a suppressor 
h n · m ·nvolved .. n nonspecific control of IgE production (14). 
· n · b, j ·m, nd Ova y reported similar findings (15). 
' 1 ·up ssor cell mechanism in mice has been shown by Katz 
(14) toe st · s circulating suppressor molecules, as yet undefined 
biochemically and immunologically, which do not appear to be immuno-
blobul·n ·n nature, do not display any antigen specificity, but are ex-
quisitely specific in terms of their capacity to negatively regulate 
responses of one immunoglobulin class, IgE. 
Studies of T cell immunodeficient diseases of humans such as 
Wiskott-Aldrich syndrome and DiGeorge's syndrome have shown a relation-
ship between decreased T cell function and increased serum IgE (16-17). 
Numerous investigators of allergic states such as atopic dermatitis 
and atopic eczema have reported decreased numbers of circulating T cells 
as well as other defects in cellular responses (18-24). Occasional 
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reports, however, have described normal numbers of T cells and intact 
cellular function in conditions with increased IgE, including atopic 
dermatitis and allergic rhinitis (25-26). Increased understanding of 
the control mechanisms involved in cellular interactions has evolved 
from studies of lymphocyte membrane markers involved in recognition and 
subsequent activation. 
SURFACE MARKERS OF T AND B LYMPHOCYTES 
THE ROSETTE PHENOMENON 
Hu n ·, nd B lymphocytes can be differentiated on the basis of 
th ir mbrane sur ace markers. \~ell recognized surface markers for 
1_ mphocytes are membrane-bound immunoglobulin (Ig), complement (C3), 
and aggregated IgG (Fe fragment) (27-29). However, the identity of 
th u ' r rs on the T cells has been poorly defined. None of 
Lh 13 markers are found on activated T cells. T lymphocytes are 
"d n · · d b th ·r ability to spontaneously bind with sheep erythrocytes 
( ·ed blood eel s, RBC) through their surface marker for sheep erythro-
cytes, and also by their ability to bind iluoresceinated T cell specif-
ic heteroantisera through their Theta surface marker (30-32). 
Discovery that T cells bear a receptor for sheep erythrocytes (33), 
while B cells carry a receptor for the third component of complement 
(34), has made possible the detection of lymphocyte subpopulations by 
rosette formation. A rosette is 3 or more sheep erythrocytes bound to 
a lymphocyte (35). (See Figure 1). Because of the limited availability 
of adequate specific heteroantisera, the sheep erythrocyte rosette 
technique has become the major method for identifying and thereby study-
ing human T cells. B cells can be identified with other methods than 
FIGURE 1. A SHEEP ERYTHROCYTE ROSETTE. 
L= LYMPHOCYTE 
E- SHEEP ERYTHROCYTE 
cell surface 
with 
ryah o yt recep or 
9 
E rosette 
B cell surface 
with E Crose te 
c3b receptor 
FIGURE 2. SURFACE RECEPTORS INVOlVED IN ROSETTE FORMATION. 
3: T CELL ' RECEPTOR FOR E 
<I E SURFACE DETERMINANT 
-< lgM AGAINST E 
a c3b 
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the rosette method such as with fluorescent antisera designed to 
detect the specific immunoglobulin (Ig) on the B cell surface. There 
are now differing opinions as to which method should be used to give 
the best results. 
T cell rosettes are commonly referred to as E rosettes, the E 
representing erythrocyte (sheep). T cell receptors for sheep erythro-
c tes b nd directly with the erythrocytes. B cell rosettes are re-
ferred to as EAC rosettes, the E for erythrocyte, the A for antibody, 
nd th o complement. B cells cannot bind sheep erythrocytes di-
rectl , but can bind to erythrocytes precoated with antibody and com-
plement. Antibody specifically against sheep erythrocytes is bound to 
receptors on the sheep erythrocyte, while the complement binds to a 
po · on o th · ntibody. B cells then can bind the membrane of the 
compl rncnt- ~ n t "body coated sheep erythrocyte through their complement 
eceptor (S igure 2). 
Factors such as pH, temperature, incubation time, and sheep ery-
throcyte to lymphocyte ratio have been shown to be critical in rosette 
formation. Variations of the technique have lead to widely disparable 
results (33, 36-39). 
Identification of T and B cells with surface markers is a qualita-
tive and quantitative measurement. The presence of normal numbers of T 
and B cells is just one of many parameters of an intact cellular and 
humoral immunity, respectively. Enumeration of the cells does not in-
dicate their functional or regulatory roles. 
THE TREAT~ffiNT OF ALLERGIES 
Allergies are commonly treated by hyposensitization. Hyposensi-
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tization is injection of the offending allergen(s) in small diluted 
concentrations over a long period of time. These injections are 
thought to activate the normal IgE inhibitory mechanisms that are dor-
mant in allergic individuals who are producing large amounts of IgE . 
These inhibitory mechanisms include IgG feedback and suppressor cells . 
gG antibody made against the injected allergen may prevent the aller-
c response by either competing with IgE for the allergen or by feed-
back "nhibiting IgE production. IgE suppressor cells may be activated 
b h y)o ns· i zation thereby reducing the production of IgE (40) . 
Antihistamines block the action of histamine released from IgE-
bound mast cells, hence the allergic symptoms are reduced or eliminated . 
Bronchodil a ors work on the smooth muscle of the bronchi which have 
ntt- t d du to histamine, SRSA, etc. released from IgE-bound mast 
'h · smooth muscle responds by relaxing thereby dilating or 
o n1n the br onch · allowing normal breathing. Both anithistamines 
nd b on hod ators are temporary treatments relieving symptoms but 
not curing them (41). 
Some allergy patients do not respond to hyposensitization or drugs 
such as the antihistamines and bronchodilators. In these patients, 
allergy symptoms are relieved temporarily with corticosteroids (42). 
Corticosteroids are thought to reduce symptoms through their action 
of suppressing the allergic response (43). Several immunosuppressive 
effects of these agents have been observed in man including mild lym-
phocytopenia (44), decreased immunoglobulin production (45), and i~ 
paired expression of skin tests (46). Despite these observations, 
little is known about the precise mechanism of the action of cortico-
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steroids on the immune response in humans (42). 
THE SIGNIFICANCE OF THE STUDY 
A detailed search of the literature has revealed numerous studies 
of T and B cell levels in atopic diseases, but very few in bronchial 
asthma. Only three known studies of asthma have examined levels of 
T and B cells in peripheral blood using surface markers. Two of these 
stud i s were with children and adolescents and the other was with 
adults. Each study explored the hypothesis that decreased levels of 
T wer associated with the asthmatic state, hoping to relate de-
pression in numerical numbers with suppressed cellular immunity. In 
ch stud attention was given to the possible effects of corticoster-
o "ds on the levels of T and B cells in peripheral blood. 
S· r · clar nd associates (47) studied 59 children and adolescents 
o re diagnosed as having rhinitis and/or asthma and atopic eczema. 
11 u ts w ·r compared to a normal control group of 30 children and 
dole ents. The found no significant difference in T cell numbers 
b twe n the p· tients ages 2 to 10 years and the normal control group. 
n adolescents ages 10 years and up, significantly fewer T cells were 
seen when compared in relative percentages to normals, but when com-
paring absolute numbers no such difference was seen. Children ages 
2 to 10 years had significantly higher B cells in both relative per-
centages and absolute numbers than did the normal control group. 
When those subjects treated with corticosteroids were separated from 
the total atopic group, there were no significant differences seen 
between the atopic and normal group. The effect of corticosteroids, 
bronchodilators, antihistamines and immunvtherapy were considered 
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and could be shown to produce no consistent effect on lymphocyte num-
bers. No attention was given to IgE levels of the patients. 
study conducted by Kue-Hsiung Hsieh (48) consisted of 60 child-
ren ages 5 to 16 years with asthma, 52 extrinsic and 8 intrinsic. Two 
normal contra groups were used, one healthy children (20 individuals) 
and one health adults (20 individuals). T cell relative percentages 
showed no d . ferences between asthmatics and normals. Absolute numbers 
of T cells showed an increase in asthmatics as compared to normals. No 
· e s re done. Some of the patients were taking bronchodi-
lato - or or icosteroids, but none had taken any steriods during the 
t o weeks preceding the T and B cell studies. IgE levels were studied 
·n th "s surve . Correlation of IgE levels and E rosettes was sought, 
bu · non ound. 
Gup , . al. (49) made the only survey of adult asthmatics, 23 
··nd · dual i n all. Sixteen of the patients were considered both ex-
t ns nd intr"nsic (mixed) asthmatics, while 7 were classified as 
~ trins ·c asthmatics. This study showed T cell levels of asthmatics 
wer d pressed significantly in relative percentages and in absolute 
numbers when compared to their normal control group. B cell numbers, 
absolute and percentages, were not significantly different from the 
control group values. Of the 23 subjects studied, only one was re-
ceiving corticosteroids as treatment at the time of the study. IgE 
levels were considered in this study with attention given to any cor-
relation of IgE and T and B cell levels in peripheral blood. No 
correlation was found. 
A study of IgE levels of asthmatics by Grove and associates (SO) 
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stated intrinsic and extrinsic asthma could not be differentiated on 
the basis of IgE levels. No T and B cells levels were done, but other 
immunological testing such as tetanus immunization was done. They 
reported on the basis of their data that asthma may be associated with 
·mmunodeficiency states. 
The effects of corticosteroids on normal human subjects have been 
stud "ed by u (51) and Fauci (42). Yu showed a decrease in T cell per-
centages, an increase in B cell percentages, and a decrease in both 
T Fnd c 1 bsolute numbers. The blood samples were drawn 6 hours 
t r dmin ' stration of the corticosteroids. Fauci showed a profound 
deere se in the absolute numbers of T and B cells 4 to 6 hours after 
administration of corticosteroids with the levels returning to normal 
b ~ v ues w"thin 24 hours. (See Figure 3, personal communique). 
I'hi tud was undertaken to investigate the clinical implication 
0 th ·onsh "p ofT and B cell levels in asthmatics. Specific 
a r s need'ng extensive research were: 
1. · 'o develop a reliable rosette technique for enumerating T and 
B cell levels in peripheral blood. 
2. To establish normal values of T and B cell levels for normal 
individuals with the developed rosette technique. 
3. To determine T and B cell levels in allergic and in asthmatic 
individuals. 
4. To determine if T and B cell levels differed in asthmatics and 
in allergic individuals compared to normals. 
5. To determine if there was any interrelationship between sex, 
age, family history, hyposensitization, duration of symptoms, 
15 
Figure 3. Personal Communique 
. D. 
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eosinophil levels, IgE levels and T and B cell levels. 
6. To determine if any relationship existed between cortico-
steroid treatment and T and B cell levels in asthmatic indi-
viduals. 
7. To determine if IgE levels were significantly different in the 
three types of asthma, intrinsic, extrinsic, and mixed. 
~~TERIALS AND METHODS 
SELECTION OF PATIENTS AND CONTROLS 
s · xty adults, 43 females and 17 males, were selected from the 
allergy clinic of Drs. Klotz and Moeller, Orlando, Florida. These pa-
tw nts were classified as either asthmatic (subdivided into intrinsic, 
extrinsic, and mixed) or allergic. Their ages ranged from 20 to 87 
y -s w"th 12 patients between 20 and 40 years, 27 patients between 
41 to 60 years, and 21 patients were 61 years and up. Of the sixty 
patients, 18 were allergic while 42 were asthmatic. Of the 42 asth-
matics, 12 were extrinsic, 15 intrinsic and 15 mixed . 
'I h no mal control group consisted of 27 persons, 11 females and 
l b 1 · 1 s , elected from the general population including college stu-
d n s, te· ch rs, secretaries, and laboratory workers. Each normal 
was carefully screened to exclude any allergies or past history of 
allergies, malignancies, recent infections (within 2 weeks), history 
o f any chronic infection, and any recent drugs or drug therapy. The 
age range of the normals was from 19 to 61 years with one person being 
19 years, 23 persons between 20 to 40 years, 2 persons between 41 to 60 
years, and one person 61 years old. 
COLLECTION OF PERIPHERAL BLOOD SAMPLES 
Venous blood was drawn from the donor with either 10 ml vacuum blood 
tubes (no anticoagulant) or with disposable 20 ml syringes using 20 
gauge needles. Two blood smears were made for leukocyte differential 
immediately upon collection of the blood, prior to addition of the 
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anticoagulant. Sodium heparin (free of preservative) was added in the 
amount of 0.4 m1 of sodium heparin concentration 2000 Units/ml to each 
10 ml of whole blood collected, then mixed gently. The heparinized 
blood was kept at room temperature and separation of the lymphocytes 
was done within 4 hours of collection. The blood smears for differen-
tials were stained with liright's stain within 4 hours of collection . 
'I ECHN ICAL CONSIDERATIONS 
In l erpretation of much of the published data concerning T and B 
n h a l th nd disease has been questionable due to the uncer-
garding technical procedure used (51). All techniques used 
n h · s stud followed the recommendations laid down by the World 
llealth Organization/International Agency for Research on Cancer 
( l U/ ') · n their special technical report of 1974 (35). An effort 
m. d to st ndardize, as much as possible, the technical proced-
u to help el ' m1nate many of the variables. In this study special con-
ide ation was addressed to the value of reporting lymphocyte levels 
in pe rcentages and in absolute numbers. The methods for separation 
and preparation of lymphocytes were adapted from the works of Dr. E. J . 
Shannon and Associates, Carville, Louisiana (52). 
STATISTICAL ANALYSIS 
The data of the patient group and normal group was subdivided into 
numerous categories as follows: 
Allergic, all (steroid and nonsteroid dependent) 
Allergic, steroid dependent 
Allergic, nonsteroid dependent 
Asthmatic, all (steroid and nonsteroid dependent; all 3 types) 
Asthmatic, all types, steroid dependent 
Asthmatic, all types, nonsteroid dependent 
Intrinsic asthmatic, all (steroid and nonsteroid dependent) 
ntrinsic asthmatic, steroid dependent 
Intrins · asthmatic, nonsteroid dependent 
E. ·tr i nsic asthmatic, all (steroid and nonsteroid dependent) 
~x ·nsic asthmatic, steroid dependent 
Extrinsic asthmatic, nonsteroid dependent 
hn · t"c, steroid dependent 
hmat·c, nonsteroid dependent 
x asthmatic, all (steroid and nonsteroid dependent) 
ormal , a l l (male and female) 
orm · , male 
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I h Stud nt's t test was performed on all data. Analyses of the 
nt r up or age, sex, IgE levels, eosinophil levels, steroid or 
o·d ependency, type of disease state, skin testing reactions, 
h_ posens·t ·,. at"on, duration of symptoms, family history and levels of 
T and B cells were performed. The normal control group was analyzed 
or age, sex, and levels of T and B cells. All T and B cell data of 
the patient group was compared to the T and B cell levels of the nor-
mal control group. Male and female T and B cell levels were combined 
in the analysis. T and B cells were reported in percentages and in 
absolute numbers. 
IgE levels were determined by the Pharmacia IgE PRIST method and 
their prescribed calculations. Since the range of IgE was great, values 
were calculated in ln then converted to the international units per 
milliliter of blood serum, U/ml. 
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Tables 1, 2 and 3 contain the raw data on the allergic, asthmatic, 
and normal 0 roups. Table 4 contains the arithmetic means and standard 
d v ' at ons for all groups forT and B cell levels. 
SEPARATION AND PREPARATION OF LYMPHOCYTES 
Separation procedure. 15 ml heparinized blood was diluted with 
5 ml cold Hank's Balanced Salt Solution (HBSS) and placed into a 30 
td c s · 1ge for dispensing. The mixture was then layered quick-
rom th~ yringe onto 7 m1 Lymphoprep(R) in a 50 ml round-bottomed 
lastic Sorvall centrifuge tube. The tube was then centrifuged 
t room emperature in a horizontal swinging head for 40 minutes at 
00 t th blood-Lymphoprep(R) interface level. The lymphocyte-
. ·h y r ( h er top of the huffy layer) was removed with a Pasteur 
p tt ( · pro. · ·mately 1 ml) and transferred to a 10 ml tube. 7 to 10 
ml o d HBSS was added to the tube and then centrifuged at 800 x g 
or 10 minutes. his was repeated for a total of 3 times with the 
supernatant be "ng removed each time by vacuum flask. On the last 
wash, 0.5 m1 of the supernatant was retained for resuspending the cells. 
Preparation procedure. Cell volume was adjusted to 2 x 106 cells/ 
ml. cell count of the lymphocyte concentration was done on the Coulter 
Counter Model ZBI; results were in cells/mm3. These results were con-
verted to cells/ml by multiplying by 103mm3/ml. The number of lymphs 
in the concentrate was divided by the number of cells desired, 2 x 106 
cells/ml to yield a ratio of cells to one milliliter of volume. The 
ratio was then multiplied by the number of mls of lymphs concentrate to 
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'1' ' b1' 1. NORNAL CONTROL GROUP 
Subject Age Sex T% Tabs B% Babs 
61 21 M 66 1294 15 294 
62 21 M 76 1146 25 377 
6 21 ~~ 70 .529 21 459 
4 - 2 M 64 1132 19 33E 
b5 21 i 66 1415 29 622 
6 3 11 70 1891 21 567 
7 t-1 84 1.870 14 312 
68 25 t1 76 J.(J08 10 133 
2 69 1615 17 39o 
I U 0 56 840 12 180 
71 3 1 60 1357 18 407 
7 3' d 75 882 15 176 
73 37 .&: 63 :178 12 224 
71. 3 1- 70 2559 10 366 
c:: r.-2 1 76 1277 15 252 
7 60 t 75 1395 14 260 
77 1 ~ 76 l.Z72 17 285 
7 20 F 79 .i739 11 24L 
7 2 F 65 1802 13 360 
0 24 F 65 1370 13 274 
7 F 56 891 16 255 
82 28 F 79 1315 12 200 
83 29 F 65 1151 8 142 
4 29 F 51 1040 12 245 
85 30 F 73 1594 15 327 
86 37 F 69 J.C'Ol 16 232 
87 59 F 52 780 3 4: 
Mean and s.d. 68.5+8.6 1348+403 14.9+5.3 295+129 
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Tabl 2. ALLERGIC GROUP 
._' ubject e SeA T% Tabs B% Babs U/ml 1n 
1 2 ~ 57 1875 30 987 15 2.7 
2 42 F 64 1338 9 188 23 3.1 
3 4 ' F 51 880 25 431 350 5.7 
l, 4( 72 1900 18 475 20 3.0 
5 51 F 64 599 9 84 96 4.6 
6 5 64 2176 15 510 18 2.9 
7 5 / 2 1240 29 499 64 4.2 
8 60 68 1083 26 414 5 1.6 
80 1286 13 209 286 5.7 ,. bl 497 12 98 17 2.8 
'•4 , ] 60 1438 18 431 60 4.1 
45 34 59 900 18 275 60 4.1 
40 ·1 71 1551 8 172 1350 7.2 
l ., '•" '·5 2129 4 7 1334 23 3.1 
l, '• 1378 9 133 5 1.6 
49 8 78 1853 9 214 445 6.1 
' 0 6 79 1048 6 80 42 3.8 
1 l 66 2641 12 480 1000 6.9 I 
.' L; d s.d . 66.9 11.4 1434+574 17. 4+1~· . 5 390+325 





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































yi ld total volume. Total volume minus the number of mls of lymphs 
concentrate equals the number of mls of diluent needed to adjust cell 
volume to a final concentration of 2 x 106 cells/ml. The lymphocytes 
were checked with acridine orange stain for purity. If greater than 
% wer eel s other than lymphocytes, a correction was made in the fi-
nal results. All lymphocytes were tested for viability using trypan 
b lue. lymphocytes were less than 90% viable, they were rejected 
f o r test ·· ng. 
0 GE s· N 
r "dine orange stain, a fluorescent stain, was prepared according 
o ------------Techniques by Humason (53). Lymphocytes appeared as 
r n mononuclear cells with one reddish-orange granule. ~Ionocytes, 
i l l ymphocytes, appeared as pale green cells with no 
c- nulocytes appeared as green cells with many reddish-orange 
nu s nd mul ·" lobed nuclei. 
s ock solution was made by adding .01 g acridine orange to 5.0 
ml 95 thanol. Excess dye was allowed to settle to the bottom and 
then was stored in the dark at 4° C until ready to use. A working so-
lution was prepared fresh for each time used. The working solution was 
made by adding 5 drops of the stock solution to 5.0 ml 95% ethanol. 
This solution was then flooded onto clean microscope slides, allowed to 
sit a few seconds, then the slides were placed vertical to dry. Slides 
were then stored in a dust free box at ro~m temperature until used. 
A drop of lymphocyte solution (2 x 106 cells/ml) was added to an 
acridine orange stained slide, then a coverslip was placed on top. The 
fresh wet mount was read immediately under an ultraviolet microscope. 
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200 cells were counted and the percent of cells other than lymphocytes 
was recorded. If greater than 1%, a corr~ction was made in the final 
results. 
V ABILITY - TRYPAN BLUE (52) 
stock solution of 1% was made by adding 1 g trypan blue to 100 
ml o HBS5 This was stored in a Nalgene plastic bottle to prevent 
1 · ch i n; h bottle was rinsed with 70% alcohol prior to the stain to 
·m·n· te bacterial contamination. The stock solution was stored at 4° 
o · n so ut"on of 0.4% was made by adding 0.4 ml filtered stock 
.o u on to 9. b ml HBSS; this was made fresh for each testing day. 
t 
lUO 
0 t . 
0.5 ml o 0.4% trypan blue was placed in a small disposable 
75 
p n b 
and allowed to equilibrate in a 37° C water bath. 
the 2 x 106 cells/ml lymphocyte solution was added 
nd incubated for 5 minutes at 37° C. The solution 
then pl d · n a Neubauer hemacytometer and 100 cells were counted 
ndom Nonv "able cells took up the stain and appeared blue. Viable 
l ymphs r m ·ned clear. If viability was less than 90%, lymphocytes 
e rej~cted for rosette assay. 
L COUNTS, HEMOGLOBINS, l-lBC DIFFERENTIALS 
All patients and normal controls had total WBC counts, RBC counts, 
hemoglobins, and WBC differentials done. Dilutions for cell counts 
were made with a Coulter automatic dilutor using Coulter reagents. The 
cell counts were performed using a Coulter Counter Model ZBI. Hemoglo-
bin samples were obtained from the WBC dilution with Coulter Zaptoglo-
bin(R). The hemoglobin concentrations were determined using a Coulter 
hemoglobinometer. All equipment was quality controlled with commercial 
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Coulter 4C control cell suspensions prior to each day's use. All cell 
counts were corrected using Coulter's coincidence charts. 
WBC differentials were determined on the blood smears stained with 
Wright's stain. 100 to 200 leukocytes were counted with each type re-
corded as a percent of the total counted. 
PREPARK ON OF SHEEP ERYTHROCYTES 
Sheep e ythrocytes in Alsever's solution were obtained from Colo-
rado S rum Company Laboratories, Denver, Colorado. 15 ml of sheep 
t h y (S C) were removed aseptically from the stock bottle 
n t ~ ~ red to two 10 m1 tubes. The SRBC were washed and centri-
·u d 3 times using a volume of 9 ml of 0.85% saline (or until the 




l urn n 
nd 
mov t ter each wash with a vacuum flask. 
0 (52) 
urn was obtained from Grand Island Biological Company, 
ew ork. This serum was heat inactivated for comple-
or 30 minutes. The serum was then absorbed with packed 
IBC (10 ml serum to 1 m1 packed SRBC) at 4° C for 30 minutes, then 
centrifuged at 800 x g for 10 minutes. The serum once absorbed was 
transferred to another 1 m1 of packed SRBC, incubated at 37° C for 
30 minutes, then centrifuged at 800 x g for 10 minutes. The superna-
tant serum was removed and stored at -20° C in aliquots of 250 micro-
liters. 
19s ANTI-SHEEP ERYTHROCYTE A!~IBODY (52) 
The source of the 19s (IgM) antisheep erythrocyte antibody was 
Cordis Laboratories, Miami, Florida. This antibody was used to prepare 
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the sheep erythrocyte-antibody-complement (EAC) complex for the B cell 
rosette method. Microtiter technique was used to titer the 19s anti-
body to determine the maximum subagglutinating dose in order to dilute 
the antibody accordingly for testing. The Cordis 19s antibody was 
ser"ally diluted with HBSS in a microtiter tray. SRBC suspensions of 
1 and 2% were added to the serially diluted antibody. Each microtiter 
was observed for hemagglutination. The end point of the hemagglu-
on reaction was read to the highest dilution. The 2% SRBC sus-
n on d d he best end point of 1:32 dilution. The 19s antibody 
s then d"luted with HBSS 1 : 32 and stored at -20° C in aliquots of 
1 l 
OUS 0 IPL 1ENT 
ro11 he common animal stock were anesthetized with 0.1 ml 
~utol "njec ed intraperitoneally using a tuberculin syringe and 24 
u n ch mouse was dissected to reveal the heart while still 
b a ing. Blood was drawn directly from the heart with a 20 gauge needle 
and tuberculin syringe. Each mouse yielded approximately 1 ml whole 
blood. B ood was allowed to clot on ice, then the serum was removed. 
5 mice yielded approixmately 2 ml serum which was ample supply for one 
month's testing. Serum was absorbed twice, first with 0.5 ml packed 
SRBC per 1 ml mouse serum at 4° C for 30 minutes, then with another 
0.5 ml packed SRBC per 1 m1 mouse serum at 37° C for 30 minutes. The 
absorbed mouse serum was aliquoted into volumes of 250 microliters and 
stored at -20° C. At time of use, the frozen serum was rapidly thawed 
in a 37° C water bath just prior to use. No mouse serum was used if more 
than one month old. 
% SOLUTIONS FOR SRBC - PREPARATION FOR EAC AND EC 
For the T cell rosette, a 0.5% solution of SRBC was prepared by 
adding .05 ml packed SRBC to 9.95 ml HBSS. 
For the B cell rosette, EAC cells and EC cells were made from a 
2.5% solution of SRBC (0.25 ml packed SRBC to 9.75 ml lffiSS). 
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To prepare EAC cells (sheep erythrocyte-antibody-complement) and 
E c lls (sheep erythrocyte-complement), a control for immune adherence, 
the allowing was done: Two 10 ml tubes were labelled, one EAC and one 
· ·o EC ube, 1.0 m1 of a 2.5% SRBC solution and 1.0 m1 of cold 
HBSS as added. To the EAC tube, 1.0 ml of a 2.5% SRBC solution and 1.0 
ml of 19s antisheep erythrocyte antibody was added. Both tubes were 
·ncubated in a 37° C shaking water bath at 60 cpm for 30 minutes. Tubes 
o ·d to cool to room temperature (5 to 10 minutes). Cells 
w hen w· shed 3 times with 3 ml cold HBSS each time at 300 x g for 
r.' m·nu Supernatant was removed each time with a vacuum flask. 
ter the last wash, the packed pellet of cells was resuspended in 2 ml 
cold HBSS. 100 microliters of mouse complement was added to each tube 
and the tubes were incubated in a 37° C shaking water bath at 60 cpm 
for 30 minutes. Cells were washed 3 times with 3 ml cold HBSS, remov-
ing the supernatant with vacuum flask each time, at 300 x g for 5 min-
utes. After the last wash, the packed pellet of cells was resuspended 
in 5 m1 cold HBSS to yield a final concentration of 0.5% suspension of 
EAC and EC cells. These solutions were stored at 4° C and used for two 
days as long as no hemolysis occurred. Cell suspensions were kept on 
ice during testing. 
THE B CELL (EAC) l~THOD 
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Two 12 x 75 mm plastic tubes were labelled, one EAC and EC. 
The following steps were taken: 
1. 
Tube EC control Tube EAC test 
Added 100 pl 0.5% EC cells 100 pl 0.5% EAC cells 
+ 100 pl 2 x 106 lymphslml + 100 pl 2 x 106 lymphslml 
2. ubes were incubated for 5 minutes in a 37° C shaking water bath 
at 60 cpm. 
1 r~fuged at 200 x g for 5 minutes. 
te el ~to cells was resuspended in its supernant by gentle 
ng unt· all of the pellet was off the bottom of the tube. 
One drop o 0.33% methylene blue was added for ease in reading. 
h y 1phoc were counted under a light microscope using a 
ub u hemac'tometer for each cell suspension of EAC and EC. 
h 1 su pens·ons were added by Pasteur pipette to both chambers 
o h hellli cytometer. A total of 200 cells, rosetted and nonro-
setted, ere counted, 100 cells per chamber. The total rosette 
number was divided by 2 to give the % EAC and % EC rosettes. The 




30 rosettes I 170 nonrosettes = Total 200 cells 
10 rosettes I 190 nonrosettes = Total 200 cells 
2 ) 20 rosettes 
10 = % B cell 
For the absolute number of B cells, the total WBC count was multiplied 
by the percentage of lymphocytes determined from the WBC differential 
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to give the total absolute lymphocyte number. The total absolute 
lymphocyte number was then multiplied by the % B cell to yield the 
total B cell absolute number. A sample calculation: 
10,000 WBC/mm3 x 30% lymphs (differential) = 3000 total absolute 
lymphocytes 
3,000 total absolute lymphs x 10% B cells = 300 total absolute 
B cell number 
THE T CELL (E) ROSETTE METHOD 
On· 75 mm plastic test tube was labelled E. The following 
p. · e re · en. 
· o he E ·ube was added 50 J.ll absorbed 10% human AB serum 
50 pl 2 x 106 lymphs/ml 
100 ).11 0. 5% SRBC 
· h tub was ·ncubated for 30 minutes in a 37° C shaking water 
ba h at 60 cpm. 
3. he tube was centrifuged at 200 x g for 5 minutes. 
4. The tube was then incubated for 60 minutes at 4° C. 
5. The pellet of cells was resuspended by gentle rocking until all 
the pellet was off the bottom of the tube. One drop of 0.33% 
methylene blue was added for ease in reading. 
6. The lymphocytes were counted under the light microscope using a 
Neubauer hemacytometer for the cell suspension. The cell suspen-
sion was added to the hemacytometer with a Pasteur pipette to 
both chambers of the hemacytometer. A total of 200 cells, rosetted 
and nonrosetted, were counted, 100 cells per chamber. The total 
rosette number was divided by 2 to give the % E rosettes. The 
% T cells equalled the % E rosettes. A sample calculation: 
E tuba 150 rosettes I 50 nonrosettes = Total 200 cells 
2 ) 150 
75 = % T cell 
35 
The absolute number of T cells was obtained by multiplying the to~ 
tal WBC count by the percentage of lymphocytes determined from the 
WBC differential to give the total lymphocyte absolute number. This 
o · l m1 hoc te absolute number was then multiplied by the % T 
ells to y"eld the total T cell absolute number. A sample calcula-
on: 
10,000 WBC/mm3 x 30% lymphs (differential) = 3000 total abso-
lute lymphocytes 
3 000 total absolute lymphs x 75% T cells = 2250 total abso-
lute T cell number 
IliMUNOGLOBUL N E 
Serum IgE levels were measured using the radioimmunoassay method, 
PRIST of Pharmacia Laboratories, Piscataway, New Jersey. 
RESULTS AND DISCUSSION 
The patient population, allergic and asthmatic, was considered 
first on the basis of sex, age, family history, hyposensitization, 
duration of symptoms, and eosinophil levels. No interrelationships 
w re seen in these areas. T and B cell levels (percent and absolute 
number) and IgE levels were considered in greater detail with attention 
be·n ve o the possible effects of corticosteroid treatment on 
hese levels. 
The normal values for the rosette assay were established as 
follows: 
c 11 percent (T%) = 68.5 + 10.6% 
cell absolute number ( Tabs) = 1345 + 403 cells/mm3 
cell percent (B%) = 14.9 + 5.3% 
B cell absolute number (Babs) = 295 + 129 cells/mm3 
he normal value for adults for IgE levels set by Pharmacia Labor a tor-
ies was 20 U/ml. 
The numerous categories of patient groups as listed on pages 18 and 
19, were compared toT cell percent, T cell absolute number, B cell 
percent, and B cell absolute number to normal values, respectively. 
Chart 1 is a summary of these comparisons. 
THE ALLERGIC GROUP - T AND B CELLS 
The allergic group, 18 individuals, was considered first as a 
whole including steroid and nonsteroid dependent. No significant dif-
ferences were seen in T and B cell percent and absolute numbers of 
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this group when compared to normal values at a 95% confidence level. 
B cell percent and B cell absolute numbers were elevated above normal 
values at a 70% and 83% confidence level, respectively. (See Table 5). 
The allergic group was then considered on the basis of steroid 
or nonsteroid dependency. The nonsteroid dependent allergies consisted 
of 7 individuals. In this group no significant differences were seen 
n and B cell percent and absolute numbars when compared to normal 
values at a 95% confidence level. T cell percent values of nonsteroid 
d nd nt allerg·cs were elevated above normal values at an 83% con-
·dence level. (see Table 6). The steroid dependent allergies con-
s s ed of 11 individuals. No significant differences were noted in T 
and B cell percent and absolute number when compared to normal values 
9 r% con 'dence level. B cell percent and B cell absolute numbers 
were e va ed above normal values at a 71% and 89% confidence level, 
es ·vel. (See Table 7). 
~ HE ASH~ C GROUP- T AND B CELLS 
The asthmatic group was first considered as a whole, 42 individ-
uals, including all types (intrinsic, extrinsic, and mixed) and ste-
roid and nonsteroid dependent. No significant differences in T and 
B ce 1 percent and absolute numbers of this group were seen when com-
pared to normal values at a 95% confidence level. (See Table 8). 
The asthmatic group was then considered including all types (in-
trinsic, extrinsic, and mixed) on the basis of steroid and nonsteroid 
dependency. The nonsteroid dependent group consisted of 6 individuals, 
while the steroid dependent group consisted of 36 individuals. No sig-
nificant differences were seen in either group in T and B cell percent 
38 
Table 5 NORMAL VS. ALLERGIC, 
STEROID AND NONSTEROID DEPENDENT 
Confidence 
Lymphocytes Normal* Allergic* Level 
T% 68.5 + 8.6 66.9 + 11.4 39% -
Tabs 1348 + 403 1434 + 574 46% 
B% 14.9 + 5.3 17.4 + 10.5 70% 
Babs 295 + 129 390 + 325 83% 
·able 6 NORMA VS. ALLERGIC, 
NONSTEROID DEPENDENT 
Confidence 
Normal Allergic, nonsteroid Level 
'1 68.5 8.6 73.6 + 10.0 83% 
Tabs 1348 + 403 1447 + 653 40% 
B 14.9 + 5. 3 16.6 + 8.1 49% -
Babs 295 + 129 328 + 179 42% 
*Values expressed are means + s.d. 
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Table 7 NORMAL VS. ALLERGIC, 
STEROID DEPENDENT 
Confidence 
Lymphocytes Normal* Allergic, steroid* Level 
T% 68.5 + 8.6 62.6 + 11.4 16% 
Tabs 1348 + 403 1426 + 552 39% 
B% 14.9 + 5. 3 17.9 + 12.2 71% 
Babs 295 + 129 429 + 395 89% 
Table 8 NORMAL VS. ASTHMATIC, ALL TYPES, 
STEROID AND NONSTEROID DEPENDENT 
Confidence 
Lymphoc tes Normal* Asthmatic* Level 
68.5 + 8.6 68.0 + 10.9 14% 
.abs 1348 + 403 1388 + 557 27% 
B' 14.9 + 5.3 15.2 + 9. 7 10% 
Babs 295 + 129 321 + 297 33% 
*Values expressed are means + s.d. 
and absolute number when compared to each other at a 95% confidence 
level. (See Table 9). 
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Each type intrinsic, extrinsic, and mixed was considered separ-
ately with each type including both steroid and nonsteroid dependent 
individuals. Intrinsic asthmatics (15 individuals), extrinsic asth-
matics (12 individuals), and mixed asthmatics (15 individuals) with 
e ·1 ·h type including steroid and nonsteroid dependent, showed no sig-
ni cant differences in T and B cell percent and absolute numbers 
1 n each t ype was compared to normal values at a 95% confidence level. 
(See ' ables 10, 11, 12). The intrinsic group, steroid and nonster-
o·d dependent, showed at a 66% confidence level decreased B cell ab-
solute number when compared to normal values. (See Table 10). Ex-
th tics steroid and nonsteroid dependent, showed an increase 
·n T cell absolute number when compared at a 63% confidence level to 
normal values. (See Table 11). The mixed asthmatic group, steroid 
and nonsteroid dependent, showed an elevated B cell absolute number 
when compared to normal values at an 83% confidence level. (See 
Table 12). 
The three asthmatic types were next considered on the basis of 
type and whether or not the individuals were steroid or nonsteroid 
dependent. The intrinsic and extrinsic nonsteroid dependent groups 
consisted of only one individual each. The intrinsic individual had 
lower T cell percent and absolute number than normal values with no dif-
ferences noted in B cell percent and absolute number. (See Table 13). 
The extrinsic individual had T cell percent and absolute number within 
normal range, but the B cell percent and absolute number were lower 
Table 9 ASTHMATIC, STEROID DEPENDENT VS. ASTHMATIC, 
NONSTEROID DEPENDENT 
Lymphocytes Asthmatic, steroid* Asthmatic, nonsteroid* 
T% 67.2 + 10.5 72.7 + 13.0 
Tabs 1382 + 588 1427 + 356 
B% 16.2 + 9.6 11.7 + 9.2 -
Babs 344 + 308 240 + 208 
T bl 0 NOIU L VS. INTRINSIC ASTHNATIC, 
STEROID AND NONSTEROID DEPENDENT 
s Normal* Intrinsic* 
68.5 + 8.6 66.1 + 10.1 
s 1348 + 403 1262 + 440 -
B% 14.9 + 5.3 13.9 + 8.4 
Babs 295 + 129 253 + 161 














Table 11 NORMAL VS. EXTRINSIC ASTHMATIC, 
STEROID AND NONSTEROID DEPENDENT 
Lymphocytes Normal* Extrinsic* 
T% 68.5 + 8.6 70.5 + 9.6 -
Tabs 1348 + 403 1513 + 766 
B% 14.9 + 5.3 15.8 + 11.3 
Babs 295 + 129 358 + 417 
r~ ble 12 NORMAL VS. MIXED ASTHMATIC, 
STEROID Al~ NONSTEROID DEPENDEN~ 
l 11phocytes Normal* Mixed* 
,-.,% 68.5 + 8.6 67.8 + 12.8 -
f'r bs 1348 + 403 1415 + 473 
B 14.9 + 5.3 16.0 + 10.3 
Babs 295 + 129 359 + 296 















Table 13 NORMAL VS. ASTHMATIC, 
NONSTEROID DEPENDENT BY TYPE 
Lymphocytes Normal* **Intrinsic* **Extrinsic* Mixed* 
T% 68.5 + 8.6 56 75 76.3 + 13.0 
Tabs 1348 + 403 1267 1458 1459 + 448 
B% 14.9 + 5.3 14 6 12.5 + 11.3 -
Babs 295 + 129 317 117 251 + 255 
*One person. 
Normal vs. Mixed, Nonsteroid 





Values expressed are mean + s.d. 
than normal values. (See Table 13). The mixed nonsteroid dependent 
group consisted of 4 individuals. No significant differences in T 
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and B cell perce~t and absolute number were seen in this group when 
compared to normal values at a 95% confidence level, but T cell per-
cent was elevated above normal values at an 89% confidence level. (See 
Table 13). 
The "ntrinsic steroid dependent asthmatic group consisted of 14 
ind"viduals. No significant differences were seen at a 95% confidence 
n · nd B cell percent and absolute number of this group when 
ompared to normal values. B cell absolute number was lower than norm-
len compared at a 69% confidence level (See Table 14). 
leven individuals made up the extrinsic steroid dependent asth-
11 r t i ou . No · . gn . ficant differences were seen in T and B cell 
nd bsolu e number of this group when compared to normal 
u s ,t 95 confidence level. T cell absolute number and B cell ab-
olute number ere elevated above normal values at a 63% and 65% con-
"dence level, respectively. (See Table 15). 
The mixed steroid dependent asthmatic group consisted of 11 in-
dividuals. No significant differences in T and B cell percent and ab-
solute number were noted when compared to normal values at a 95% con-
idence level. T cell percent for this group was lower than normal at 
a 71% confidence level. B cell percent and absolute number were ele-
vated above normal values at a 65% and 86% confidence level, respect-
ively. (See Table 16). 
T AND B CELLS IN SUMMARY 
The values of T and B cell levels in this study did not show 
Table 14 NORMAL VS. INTRINSIC ASTHMATIC, 
STEROID DEPENDENT 
Lymphocytes Normal* 
T% 68.5 + 8.6 -
Tabs 1348 + 403 
B% 14.9 + 5.3 
Babs 295 + 129 
, b e 15 NORMAL VS. EXTRINSIC ASTHMATIC, 
STERO D DEPENDENT 
te Normal* 
68.5 + 8. 6 
1 bs 1348 + 403 
B% 14.9 + 5.3 
Babs 295 + 129 




66.8 + 10.1 41% 
1262 + 456 47% 
13.9 + 8.7 38% 
248 + 166 69% 
Confidence 
Extrinsic* Level 
70.1 + 9.9 41% 
1518 + 803 63% 
16.5 + 11.5 48% 
380 + 430 65% 
Table 16 NORMAL VS. MIXED AST~lliATIC, 
STEROID DEPENDENT 
Lymphocytes Normal* 
T% 68.5 + 8.6 
Tabs 1348 + 403 
B% 14.9 + 5.3 
Babs 295 + 129 
.·~values expressed are mean + s.d. 
46 
Confidence 
Mixed, Steroid* Level 
64.7 + 11.8 71% 
1399 + 502 27% 
17.3 + 10.2 65% -
399 + 311 86% 
47 
statistically at a high level of confidence, 95%, significant differ-
ences between the patient groups and normals. What was seen at lower 
confidence levels was best depicted visually with scattergram diagrams. 
(See Charts 2-21). Each category of disease state was diagrammed with 
steroid (s) dependent, nonsteroid (n) dependent, and normal control 
(c) values plotted against age in order to give a well distributed 
d·· gram for easy visual examination. Although definite differences 
were not seen, there were trends as follows: (See Chart 1). 
11 ·rg·c individuals when considered as a whole, steroid and 
nonsteroid dependent, appeared normal in their T cell percent and 
bsolute number while their B cell percent and absolute number appeared 
slightly elevated. 
2. thmatic individuals including all three types (intrinsic, 
~ rinsic, and mixed) and steroid and nonsteroid dependent when con-
s·d r d as a whole appeared normal in their T cell and B cell percent 
and absolute number. 
3. No significant differences were seen in T and B cell percent 
and absolute number between intrinsic, extrinsic, and mixed asthmatics. 
4. Intrinsic asthmatics, both steroid and nonsteroid dependent 
combined, appeared to have slightly lower B cell absolute number. They 
appeared normal in B cell percent, T cell percent and T cell absolute 
number. 
5. Extrinsic asthmatics, steroid and nonsteroid dependent, ap-
peared to have slightly elevated T cell absolute numbers. They appeared 
normal in T cell percent, B cell percent, and B cell absolute number. 
6. Mixed asthmatics, steroid and nonsteroid dependent, appeared 
48 
Chart 1 SUMMARY OF NORMAL VS. ALLERGIC AND ASTHMATIC 
T AND B CELL LEVELS 
T% Tabs B% Babs 
Allergic, All t _t_ 
Allergic, Steroid t t 
Allergic, Nonsteroid t 
sthmatic, All 
sthmatic, Steroid t • 
'thn ic, Nonsteroid 
'If 
ln r· c, All 
' nt ·nsic, Steroid 
' Int ins c, Nonsteroid* 
ins c, 1 t 
rins·c, Steroid t t 
Extrinsic, Nonsteroid* 
' + Mixed, All t 
Mixed, Steroid t t 
' Mixed, Nonsteroid t 











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































to have slightly elevated B cell absolute number. They appeared 
normal in B cell percent, T cell percent and T cell absolute number. 
69 
7. In all steroid dependent individuals, regardless of the general 
disease state, allergic or asthmatic, T cell percent and absolute 
number appeared normal while B cell percent and absolute number appeared 
elevated. 
8. In all steroid dependent individuals, regardless of the general 
disease state, allergic or asthmatic, T cell percent appeared elevated 
wh "le T cell absolute number appeared normal. The allergies of this 
group appeared normal in their B cell percent and absolute number. The 
asthmatics of this group, however, qppeared to have lower B cell percent 
while their B cell absolute number appeared normal. 
9. ntrinsic asthmatics, nonsteroid dependent, appeared lower in 
I cell percent and absolute number, while their B cell percent and 
absolute number appeared normal. 
10. Extrinsic asthmatics, nonsteroid dependent, appeared normal in 
T cell percent and absolute number, while their B cell percent and 
absolute number appeared lower. 
11. Mixed asthmatics, nonsteroid dependent, appeared to have ele-
vated T cell percent, while their T cell absolute number appeared normal. 
B cell percent and absolute number appeared normal. 
12. Intrinsic asthmatics, steroid dependent, appeared normal in T 
cell percent and absolute number, and B cell percent levels, but showed 
a decrease in B cell absolute number. 
13. Extrinsic asthmatics, steroid dependent, appeared normal in 
T cell percent and B cell percent levels, but were elevated in T cell 
70 
absolute number and B cell absolute number. 
14. Mixed asthmatics, steroid dependent, showed decreased T cell 
percent levels, normal T cell absolute levels, and increased B cell 
percent and absolute number. 
The effects of corticosteroids on T and B cell levels in asthmatics 
were considered in this study. Other investigators (48-50) made the 
assumption that asthma was a state of suppressed cellular immunity, the 
T cell side, and used levels of T and B cells in peripheral blood as 
·ndicators o th·s suppression. These investigators reported decreased 
levels of T cells in asthmatics, but their patient populations studied 
were primarily nonsteroid dependent individuals. Combining the theory 
of suppressed cellular immunity in asthmatics, the assumption that 
1 cell levels can be an indicator of such suppression, and the known 
c so corticosteroids in normal individuals (See Page 14), a con-
clusion that T and B cell levels should be decreased in steroid de-
pendent asthmatics could be derived. This study, however, showed the 
opposite: T and B cell levels appeared normal or elevated in steroid 
dependent asthmatics. If asthma is truly a state of suppressed cel-
lular immunity, then the corticosteroids appear to have the ability to 
stimulate the T and B cell production rather than suppress them. The 
action of the corticosteroids could be directly on the T helper cell to 
stimulate it or on the T suppressor cell to turn it off and allow the 
T helper cell to function. Clearly further studies of asthmatics 
in regard to the effect of corticosteroids on T helper and suppressor 
cell functions is an area worthy of attention, since such studies could 
have implications for future treatments. 
71 
THE ALLERGIC GROUP - IgE LEVELS 
The allergic group consisting of 18 individuals ranged from IgE 
values of 5 to 1350 U/ml. The geometric mean for this group was 41.9 
+ 5.1 U/ml. The normal IgE serum value is 20 U/ml. 
THE ASTHMATIC GROUP - IgE LEVELS 
The asthmatic group was considered by type for IgE levels. In-
tr ·nsic asthmatics, 11 steroid and 1 nonsteroid dependent, had a geo-
metric mean of 12.5 + 2.8 U/ml. Extrinsic asthmatics, 10 steroid and 
nonsteroid dependent, had a geometric mean of 45.4 + 1.8 U/ml. l1ixed 
a thmatics, 11 steroid and 4 nonsteroid dependent, had a geometric mean 
of 125.7 + 2.66. Since both the intrinsic and extrinsic groups had only 
one nonsteroid dependent individual each, no further analysis could 
b on ·. Th mixed group, however, was divided further on the basis 
o teroid dependency. Mixed asthmatics, nonsteroid dependent had a 
eometric mean of 70.8 + 1.7 U/ml., while the steroid dependent mixed 
as hmatics had a geometric mean of 157.8 + 2.7 U/ml. Charts 22-24 show 
the IgE levels in histogram form. 
gE LEVELS IN SUMMARY 
Eleven out of the 18 allergic individuals were steroid dependent. 
The geometric mean of 41.9 + 5.1 U/ml indicates that steroids did not 
decrease the IgE levels in this group. 
IgE levels in the asthmatics showed more dramatically the value 
of such a test in this disease state. IgE was shown to be significant 
at a 95% confidence level in distinguishing the three types of asthma, 
intrinsic, extrinsic, and mixed. 
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considered by type. All three types of asthma did not show a decrease 
in IgE levels with steroids, except intrinsic IgE values were lower 
than the normal 20 U/ml but not significantly lowered. Extrinsic and 
intrinsic asthmatics consisted of all steroid dependent individuals 
except two. Extrinsic asthmatics' IgE levels were much higher than the 
normal value. Mixed asthmatics showed a definite difference between 
steroid and nonsteroid dependent individuals, but still both IgE levels 
ere much higher than the normal values. Steroids did not decrease 
h evels ·n the mixed asthmatic individuals. IgE levels in the steroid 
dep ndent mixed asthmatics were higher than in the nonsteroid dependent 
mixed asthmatics suggesting perhaps that a decrease in the T suppressor 
cell f unction has occurred which would correlate with the decrease in 
c percent observed in the steroid dependent patients, while the 
101 t ·o · d dependent patients showed an increase in T cell percent. 
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